Prentice, Ross L <br/><br/>
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.  [electronic resource] 

 -  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology  Nov 2009 
 - 3079-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-7755 
<br/><br/><label>Standard No.: </label>10.1158/1055-9965.EPI-09-0611  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--diagnosis<br/>Case-Control Studies<br/>Cohort Studies<br/>Estrogen Replacement Therapy<br/>Estrogens--therapeutic use<br/>Female<br/>Genotype<br/>Humans<br/>Introns--genetics<br/>Linkage Disequilibrium<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Polymorphism, Single Nucleotide--genetics<br/>Postmenopause--genetics<br/>Progestins--therapeutic use<br/>Prognosis<br/>Receptor, Fibroblast Growth Factor, Type 2--genetics<br/>Risk Factors